Biotech

All Articles

ReNeuron leaving intention swap after skipping fundraising goal

.ReNeuron has signed up with the long list of biotechs to leave Greater london's purpose stock marke...

MBX apply for IPO to take opposition to Ascendis into phase 3

.MBX Biosciences has contributed to the recent outbreak of IPO filings. The biotech, which submitted...

FDA grows probe in to Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and the company's would-be MDMA-assisted treatment for trauma (PTSD), the fa...

Gene editor Volume laying off 131 workers

.Just days after gene editor Tome Biosciences declared unrevealed working slices, a clearer picture ...

Repare lays off 25% of team as biotech standstills preclinical R&ampD

.Repare Rehab is actually giving up a quarter of its staff as the oncology biotech downsize its prec...

J &amp J apply for FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken yet another measure towards recognizing a return on its own $6.5 bil...

Gain's period 1 gain paves method to prove Parkinson's medicine's worth

.Increase Rehabs has established its own sights on showing the effectiveness of its own Parkinson's ...

Actinogen records new stage 2 records to recover anxiety drug

.Actinogen Medical's hopes-- as well as supply cost-- have actually rebounded somewhat from earlier ...

Pfizer and Main incorporate Quotient to multibillion-dollar equation

.Front Runner Pioneering as well as Pfizer have included Quotient right into their 10-program collab...

Bayer markers $547M treaty to push boundaries of noncoding RNA

.Bayer managers were keen to tension to Intense this summer months that the German pharma titan's cr...